查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1612570

生物標記測試服務市場：按服務、技術、疾病領域、應用、最終用戶分類 - 全球預測 2025-2030

Biomarker Testing Services Market by Services, Techonology, Disease Area, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

生物標記測試服務市場2023年估值為9.649億美元，預計到2024年將達到10.3196億美元，複合年成長率為7.34%，預計到2030年將達到15.8504億美元。

生物標記測試服務包括利用生物標記檢測、評估和監測健康狀況的診斷過程，特別是在腫瘤學、神經病學、心臟病學和感染疾病方面。這種測試對於精準醫學至關重要，可以根據個人的基因譜量身定做治療方案，通常會帶來更好的結果。生物標記測試的應用範圍包括早期疾病診斷、治療指南、預後和監測治療反應。市場的主要最終用戶是醫院、診斷實驗室、研究機構和製藥公司。關鍵的成長要素包括慢性病的增加、基因組學和蛋白​​質組學的進步以及對個人化醫療的日益關注。技術進步，特別是次世代定序和數位化診斷，為擴大和改進生物標記的應用提供了機會。公司可以透過投資與基因組研究機構建立合作夥伴關係和共同開發來開發聯合品牌診斷解決方案來獲得資金。

主要市場統計
基準年[2023] 9.649 億美元
預計年份 [2024] 1,031,960,000 美元
預測年份 [2030] 15.8504億美元
複合年成長率（%） 7.34%

然而，該市場面臨局限性，例如與生物標記發現和檢驗相關的高成本、多分析物檢測的監管挑戰以及資料管理問題。各種生物標記的標準化和整合以進行綜合分析也面臨挑戰。創新應著重於透過自動化整合平台降低成本、加強資料整合策略以及開發強大且可擴展的檢驗方法。另一個有前景的領域是人工智慧的整合，以簡化生物標記的發現和資料解釋過程。這個市場充滿活力，其特點是技術快速進步和透過附加價值服務實現競爭差異化。該領域的成功需要採取策略方法來促進合作研究、投資先進技術並遵守法規環境。掌握行業趨勢並優先考慮以客戶為中心的創新對於在不斷變化的環境中抓住市場機會並推動公司發展至關重要。

市場動態：針對快速發展的生物標記測試服務市場揭示的關鍵市場洞察

供需的動態交互作用正在改變生物標記測試服務市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 抗癌藥物開發的增加和對高性能生物標記的需求
    • 政府對生物標誌研究的措施和投資
    • 加強對生物標記檢測的財政支持
  • 市場限制因素
    • 生物標記測試既耗時又昂貴
  • 市場機會
    • 使用人工智慧和機器學習的生物標記測試工具和設備的進步
    • 提供生物標記測試和分析服務的 CDMO 的出現
  • 市場挑戰
    • 由於樣本採集和缺乏真實性而造成測試障礙

波特五力：駕馭生物標記測試服務市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解生物標記測試服務市場的外部影響

外部宏觀環境因素在塑造生物標記測試服務市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解生物標記檢測服務市場的競爭狀況

生物標記測試服務市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣生物標記測試服務市場供應商的績效評估

FPNV 定位矩陣是評估生物標記測試服務市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃生物標記測試服務市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，生物標記測試服務市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 癌症藥物開發的增加和對高性能生物標記的需求
      • 政府對生物標誌研究的措施和投資
      • 改善生物標記測試的財務支援的可用性
    • 抑制因素
      • 生物標記測試是一個緩慢且昂貴的過程
    • 機會
      • 使用人工智慧和機器學習的生物標記測試工具和設備的進步
      • 提供生物標記測試和分析服務的新興 CDMO
    • 任務
      • 由於樣本收集和缺乏可靠性而造成測試障礙
  • 市場區隔分析
    • 技術：不斷進步，提升聚合酵素鏈鎖反應技術的通用性、速度和擴增能力
    • 最終用戶：生物標記測試服務在製藥和生物技術公司治療性介入的新用途
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章生物標記測試服務市場：依服務分類

  • 生物標記測定的開發和檢驗
  • 流式細胞技術

第7章生物標記檢測服務市場技術

  • 酵素免疫分析法
  • 質譜分析
  • 次世代定序
  • 聚合酵素鏈鎖反應

第8章依疾病領域分類的生物標記檢測服務市場

  • 自體免疫疾病
  • 癌症
  • 心血管疾病
  • 神經系統疾病

第9章生物標記測試服務市場：依應用分類

  • 藥物作用機制
  • 動態
  • 預測性臨床研究
  • 預後

第 10 章 生物標記測試服務市場：依最終用戶分類

  • 合約調查機構
  • 製藥和生物技術公司
  • 調查機構

第11章美洲生物標記檢測服務市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太生物標記檢測服務市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲/中東/非洲生物標記檢測服務市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Mayo Clinic Laboratories 和 Progentec 合作為自體免疫疾病患者提供先進的生物標記檢測服務
    • 新的前列腺癌生物標記測試登陸美國市場
    • Quanterix 推出 LucentAD 生物標記血液檢測，幫助醫生診斷阿茲海默症患者
  • 戰略分析和建議

公司名單

  • Abcam PLC by Danaher Corporation
  • Agilent Technologies, Inc.
  • Avid Bioservices, Inc.
  • Bio-Rad Laboratories, Inc.
  • BioAgilytix Labs
  • BiomarkerBay BV
  • Bristol Myers Squibb
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • Icon PLC
  • Intertek Group PLC
  • IQVIA
  • JSR Life Sciences, LLC
  • KCAS Group
  • Laboratory Corporation of America Holdings
  • LGC Group
  • Merck KGaA
  • Myriad Genetics, Inc.
  • NeoGenomics Laboratories
  • Parexel International Corporation
  • PerkinElmer Inc.
  • Randox Laboratories
  • SGS SA
  • Shuwen Biotech Co., Ltd.
  • Syneos Health
  • Thermo Fisher Scientific, Inc.
  • WuXi Biologics Inc.
Product Code: MRR-B16853779DF0

The Biomarker Testing Services Market was valued at USD 964.90 million in 2023, expected to reach USD 1,031.96 million in 2024, and is projected to grow at a CAGR of 7.34%, to USD 1,585.04 million by 2030.

Biomarker testing services encompass diagnostic processes that utilize biomarkers to detect, evaluate, and monitor health conditions, particularly in oncology, neurology, cardiology, and infectious diseases. This testing is essential for precision medicine, wherein treatments can be tailored to the individual's genetic profile, often leading to better outcomes. The application of biomarker testing spans early disease diagnosis, therapeutic guidance, prognosis, and monitoring treatment response. Within the market, the primary end-users are hospitals, diagnostic laboratories, research organizations, and pharmaceutical companies. Key growth factors include the rise in chronic diseases, advancements in genomics and proteomics, and an increased focus on personalized medicine. Technological advancements, particularly in next-generation sequencing and digitalized diagnostics, present opportunities to expand and refine biomarker applications. Companies can capitalize by investing in partnerships and collaborations with genomic research entities to develop co-branded diagnostic solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 964.90 million
Estimated Year [2024] USD 1,031.96 million
Forecast Year [2030] USD 1,585.04 million
CAGR (%) 7.34%

However, the market faces limitations such as high costs associated with biomarker discovery and validation, regulatory challenges around multi-analyte assays, and data management issues. Challenges also arise in standardization and the integration of diverse biomarker types for comprehensive analysis. Innovations should focus on reducing costs via automated and integrated platforms, enhancing data integration strategies, and developing robust, scalable validation methodologies. Another promising area is the integration of AI to streamline biomarker discovery and data interpretation processes. The market is highly dynamic, characterized by rapid technological advancements and competitive differentiation through value-added services. Success in this field requires a strategic approach towards fostering collaborations, investing in advanced technologies, and complying with regulatory environments. Staying updated with industry trends and prioritizing customer-centric innovations will be crucial to capturing market opportunities and driving company growth in this evolving landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biomarker Testing Services Market

The Biomarker Testing Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing cancer drug development and need for high-performing biomarkers
    • Government initiatives and investments for biomarker research
    • Improved availability of financial coverage for biomarker testing
  • Market Restraints
    • Time-consuming and expensive process of biomarker testing
  • Market Opportunities
    • Advancements in biomarker testing tools & equipment with AI & ML
    • Emerging CDMOs offering biomarker testing and analysis services
  • Market Challenges
    • Barriers in testing due to lack of sample collection and authenticity

Porter's Five Forces: A Strategic Tool for Navigating the Biomarker Testing Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biomarker Testing Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biomarker Testing Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biomarker Testing Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biomarker Testing Services Market

A detailed market share analysis in the Biomarker Testing Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biomarker Testing Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biomarker Testing Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biomarker Testing Services Market

A strategic analysis of the Biomarker Testing Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biomarker Testing Services Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC by Danaher Corporation, Agilent Technologies, Inc., Avid Bioservices, Inc., Bio-Rad Laboratories, Inc., BioAgilytix Labs, BiomarkerBay B. V., Bristol Myers Squibb, Eurofins Scientific SE, F. Hoffmann-La Roche AG, Icon PLC, Intertek Group PLC, IQVIA, JSR Life Sciences, LLC, KCAS Group, Laboratory Corporation of America Holdings, LGC Group, Merck KGaA, Myriad Genetics, Inc., NeoGenomics Laboratories, Parexel International Corporation, PerkinElmer Inc., Randox Laboratories, SGS S.A., Shuwen Biotech Co., Ltd., Syneos Health, Thermo Fisher Scientific, Inc., and WuXi Biologics Inc..

Market Segmentation & Coverage

This research report categorizes the Biomarker Testing Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Services, market is studied across Biomarker Assay Development & Validation and Flow Cytometry.
  • Based on Techonology, market is studied across Enzyme-Linked Immunosorbent Assay, Mass Spectrometry, Next-Generation Sequencing, and Polymerase Chain Reaction.
  • Based on Disease Area, market is studied across Autoimmune Diseases, Cancer, Cardiovascular Diseases, and Neurological Disorders.
  • Based on Application, market is studied across Drug Mechanism of Action, Pharmacodynamic, Predictive Clinical Studies, and Prognostic.
  • Based on End-User, market is studied across Contract Research Oraganizations, Pharmaceutical & biotechnology companies, and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing cancer drug development and need for high-performing biomarkers
      • 5.1.1.2. Government initiatives and investments for biomarker research
      • 5.1.1.3. Improved availability of financial coverage for biomarker testing
    • 5.1.2. Restraints
      • 5.1.2.1. Time-consuming and expensive process of biomarker testing
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in biomarker testing tools & equipment with AI & ML
      • 5.1.3.2. Emerging CDMOs offering biomarker testing and analysis services
    • 5.1.4. Challenges
      • 5.1.4.1. Barriers in testing due to lack of sample collection and authenticity
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Ongoing advancements to improve the versatility, speed, and amplification capabilities of polymerase chain reaction technology
    • 5.2.2. End-User: Emerging utilization of biomarker testing services by pharmaceutical & biotechnology companies for therapeutic interventions
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biomarker Testing Services Market, by Services

  • 6.1. Introduction
  • 6.2. Biomarker Assay Development & Validation
  • 6.3. Flow Cytometry

7. Biomarker Testing Services Market, by Techonology

  • 7.1. Introduction
  • 7.2. Enzyme-Linked Immunosorbent Assay
  • 7.3. Mass Spectrometry
  • 7.4. Next-Generation Sequencing
  • 7.5. Polymerase Chain Reaction

8. Biomarker Testing Services Market, by Disease Area

  • 8.1. Introduction
  • 8.2. Autoimmune Diseases
  • 8.3. Cancer
  • 8.4. Cardiovascular Diseases
  • 8.5. Neurological Disorders

9. Biomarker Testing Services Market, by Application

  • 9.1. Introduction
  • 9.2. Drug Mechanism of Action
  • 9.3. Pharmacodynamic
  • 9.4. Predictive Clinical Studies
  • 9.5. Prognostic

10. Biomarker Testing Services Market, by End-User

  • 10.1. Introduction
  • 10.2. Contract Research Oraganizations
  • 10.3. Pharmaceutical & biotechnology companies
  • 10.4. Research Institutes

11. Americas Biomarker Testing Services Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Biomarker Testing Services Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Biomarker Testing Services Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Mayo Clinic Laboratories and Progentec Collaborate To Bring Advanced Biomarker Testing Services To Patients With Autoimmune Diseases
    • 14.3.2. Novel Prostate Cancer Biomarker Test Launches on US Market
    • 14.3.3. Quanterix Launches LucentAD Biomarker Blood Test To Aid Physician Diagnosis of Alzheimer's Disease In Patients
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam PLC by Danaher Corporation
  • 2. Agilent Technologies, Inc.
  • 3. Avid Bioservices, Inc.
  • 4. Bio-Rad Laboratories, Inc.
  • 5. BioAgilytix Labs
  • 6. BiomarkerBay B. V.
  • 7. Bristol Myers Squibb
  • 8. Eurofins Scientific SE
  • 9. F. Hoffmann-La Roche AG
  • 10. Icon PLC
  • 11. Intertek Group PLC
  • 12. IQVIA
  • 13. JSR Life Sciences, LLC
  • 14. KCAS Group
  • 15. Laboratory Corporation of America Holdings
  • 16. LGC Group
  • 17. Merck KGaA
  • 18. Myriad Genetics, Inc.
  • 19. NeoGenomics Laboratories
  • 20. Parexel International Corporation
  • 21. PerkinElmer Inc.
  • 22. Randox Laboratories
  • 23. SGS S.A.
  • 24. Shuwen Biotech Co., Ltd.
  • 25. Syneos Health
  • 26. Thermo Fisher Scientific, Inc.
  • 27. WuXi Biologics Inc.

LIST OF FIGURES

  • FIGURE 1. BIOMARKER TESTING SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. BIOMARKER TESTING SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. BIOMARKER TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. BIOMARKER TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOMARKER TESTING SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOMARKER TESTING SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY BIOMARKER ASSAY DEVELOPMENT & VALIDATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DRUG MECHANISM OF ACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PHARMACODYNAMIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PREDICTIVE CLINICAL STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PROGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORAGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 238. BIOMARKER TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. BIOMARKER TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023